SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-242083
Filing Date
2018-08-08
Accepted
2018-08-08 09:05:35
Documents
4
Period of Report
2018-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d603163d8k.htm 8-K 15482
2 EX-99.1 d603163dex991.htm EX-99.1 43073
3 GRAPHIC g603163capture.jpg GRAPHIC 15740
4 GRAPHIC g603163g0803070604041.jpg GRAPHIC 3705
  Complete submission text file 0001193125-18-242083.txt   81507
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 18999986
SIC: 2834 Pharmaceutical Preparations